Related Experiment Video

Updated: Apr 21, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

4.6K

Takotsubo's Cardiomyopathy in a Patient with Kartagener's Syndrome

Luis W Dominguez1, Robert P Doggette1, Fernando Gonzalez-Ibarra2

  • 1Department of Internal Medicine, Jersey City Medical Center, 355 Grand Street, Jersey City, NJ 07302, USA ; St. George's University School of Medicine, St. George's, Grenada.

Case Reports in Medicine
|November 12, 2014
PubMed

Insights

This case report details the first known instance of Takotsubo cardiomyopathy in a young patient with Kartagener's syndrome. The condition resolved within four weeks, suggesting a potential link between chronic lung disease and this cardiac phenomenon.

Area of Science:

  • Cardiology
  • Pulmonology
  • Genetics

Background:

  • Kartagener's syndrome is a rare genetic disorder affecting cilia, leading to chronic lung disease.
  • Takotsubo cardiomyopathy, or stress-induced cardiomyopathy, is a transient heart condition.
  • The interplay between chronic lung disease and cardiac function is not fully understood.

Purpose of the Study:

  • To report the first case of Takotsubo cardiomyopathy in a patient with Kartagener's syndrome.
  • To explore the potential contribution of chronic lung disease to Takotsubo cardiomyopathy.
  • To highlight the importance of considering non-coronary causes of myocardial infarction symptoms.

Main Methods:

  • Case report of a 46-year-old male with Kartagener's syndrome, hypertension, and HIV.
  • Clinical presentation of acute chest pain, ECG, troponin levels, and ventriculography.
  • Coronary catheterization to rule out obstructive coronary artery disease.
  • Monitoring of left ventricular function and ejection fraction (EF) over four weeks.

Main Results:

  • The patient presented with symptoms consistent with acute myocardial infarction.
  • Ventriculography revealed left ventricular dyskinesia with a reduced EF of 25%.
  • Coronary arteries were found to be non-obstructed.
  • Ventricular function and EF recovered to normal levels within four weeks.

Conclusions:

  • This is the first reported case of Takotsubo cardiomyopathy in a young patient with Kartagener's syndrome.
  • Chronic lung disease associated with Kartagener's syndrome may be a contributing factor to Takotsubo cardiomyopathy.
  • Further research is needed to elucidate the pathophysiology of Takotsubo cardiomyopathy in patients with underlying lung conditions.

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.4K
Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

2.8K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
814
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
943
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
889
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
732
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
598